>


EU REACH

What is REACH?
REACH (Regulation (EC) 1907/2006) is European Union legislation that deals with the Registration, Evaluation, Authorisation and Restriction of Chemicals. It entered into force on 1 June 2007. The aim of REACH is to improve the protection of human health and the environment through the better and earlier identification of the properties of chemical substances.
REACH gives greater responsibility to the industry to manage the risks from products and to provide safety information on substances. Manufacturers and importers are required to submit information on the properties of their chemical substances to a central database run by the European Chemicals Agency (ECHA) in Helsinki.
CBMM and REACH
As an importer, CBMM Europe BV registered all its imported substances covering all their potential uses in Europe with ECHA, allowing the Company to continue supplying its customers.
CBMM Europe BV is the Substance Information Exchange Forum (SIEF) Formation Facilitator (SFF) and Lead Registrant (LR) for niobium metal,  niobium pentoxide and ANO. More information about these substances and SIEF decisions can be found at the REACH-IT webpage.
(1) the right to refer to studies submitted with the original 2010 dossier are granted free of charge and can be accessed under the “Test Reports” section and (2) the right to refer to new studies for Niobium and Niobium Pentaoxide required by ECHA’s decisions of July 28, 2020 require a Letter of Access which is being managed through Steptoe & Johnson LLP (contact GRosini@Steptoe.com).

Safety Data Sheets (SDS) updated according to REACH and CLP (Classification, Labeling and Packaging) regulations are offered by CBMM for its products. This information is provided to ensure the safe handling and use of the Company's products.

Helpful Links
Additional information on REACH can be found at the following institutional websites: 
Meanwhile, if you have questions regarding the registration of CBMM products and REACH, please contact CBMM Europe BV via email or at +31 (0) 20-881-3142.


Test Reports*

ANO
Dinobium Pentaoxide
Niobium
Acute Dermal Irritation_Corrosion
Acute Inhalation Toxicity in Rats
Assessment of Acute Toxic Effects on Rainbow Trout Oncorhynchus mykiss Teleostei Salmonidae Amendmen
Assessment of Toxic Effects on Daphnia magna Using the 48 h Acute Immobilisation Test
Bioconcentration study of ANO in common carp
Bioconcentration study of ANO in common carp amendment
Biodegradation test
In vitro Mammalian Cell Gene Mutation Assay in Mouse Lymphoma L5178Y Cells
Metal corrosivity A1400621_0
Reverse Mutation Assay using Bacteria Salmonella typhimurium
Screening for the Eye Irritancy Potential using the Bovine Corneal Opacity and Permeability Assay
SIP_ANO_15JUNE2018
Test for Sensitisation Local Lymph Node Assay  LLNA
Testing of Effects to the Single Cell Green Alga Pseudokirchneriella subcapitata
Aberration Test in vitro_Nb2O5
Acute Dermal Toxicity_Nb2O5
Acute Oral ToxicityNb2O5 092576A
AnalyticsNb2O5 2009007405
CSR_Nb2O5_Feb2018
Diniobium pentaoxide 1313-96-8 AcuteInhalation
Diniobium pentaoxide 1313-96-8 AmesTest
Diniobium pentaoxide 1313-96-8 EyeIrritation
Diniobium pentaoxide 1313-96-8 SkinIrritation
Eye Irritancy Potential HETNb2O5 B
FlamabilityNb2O5 S0902888
GranulometryNb2O5 2009007404
In vitro Skin CorrosionNb2O5 2568B
Literature Survey Report - Diniobium pentaoxide
Mutation Assay in vitroNb2O5 092575B
Oxidizing PropertiesNb2O5 S0902889
Sensitization LLNANb2O5 092572B
Sludge RespirationNb2O5 S0902690
Statement AdsordesorNb2O5 S0902686
Water Solubility OECD29Nb2O5 S1002669
Water SolubilityNb2O5 2009007401
Reverse Mutation AssayNb 092573A
Oral Dose Range Finding 14day_Nb2O5 (092768)
Repeated dose toxicity and reproduction_Nb2O5 (092790)
Report_Bioaccessibility_Nb2O5
Self Ignition_Nb2O5 (200901118)_A
Aberration Test in vitroNb 092574A
Acute Dermal IrritationNb 092569A
Acute Dermal ToxicityNb 092577A
Acute Eye IrritationNb 092571A
Combined dose study
Eye Irritancy Potential HETNb A
Final_Study Report_Nb bioaccessibility
Flammability
In vitro Skin CorrosionNb 2568A
Inhalation Study
Literature Survey Report - Niobium
Mutation Assay in vitroNb 092575A
Reverse Mutation AssayNb 092573A
Self ignition
Oxidizing                       
Particle size 
Self Ignition_Nb (200901121)
Sensitization LLNA_Nb (092572A)
Sieve analysis
SIP_Niobium_21DEC2017
Water Solubility OECD29_Nb (S10-02668)
Water Solubility OECD29_Nb (S10-02668)
Water solubility
Water Solubility_Nb (2009_0073_01)
Water solubility 2


*Disclaimer

 

By downloading these electronic files, you agree that your use of the electronic file is subject to the following license terms and conditions and Privacy Policy.

Clause 1 License Terms & Conditions

i. CBMM Europe BV (CBMM) is the owner of the information on niobium contained in these electronic files (the Information). 

ii. You are hereby authorized to download, print or make copies of these electronic files and use the content of these electronic files or of any part of the Information exclusively for your [company’s] internal purposes. Nothing in this disclaimer shall be construed as a transfer of the ownership in the intellectual property rights as listed under Clause 2. 

iii. You may not sell or otherwise exploit these electronic files, or any portion of them, for any other purposes, without express written and prior consent of CBMM.

iv. You may not modify these files. 

v. Any unauthorized use automatically terminates the license granted to you by CBMM under this clause. 

vi. The Information was generated for the purpose of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and the Information has been agreed within the Niobium SIEF. CBMM does not offer any warranties or guarantees concerning the accuracy, the usefulness, validity or completeness of the Information. CBMM is not liable or responsible for errors or omissions in the content of the Information. 

vii. The Information is provided for general informational and educational purposes only, and may not be viewed as scientific advice of any sort. The purpose of this Information does not include providing any scientific recommendations, advice or guidelines for the use of substances or products produced or sold by CBMM, or developed by CBMM, companies affiliated and related to it, licensees or joint venture partners. Information concerning substances or products must be viewed with the necessary reservations and more specifically in reference to the complete data on the method of preparation concerning these products. 

viii. You shall indemnify CBMM against all liabilities, costs, expenses, damages and losses suffered or incurred by CBMM arising out of or in connection with your downloading, saving copies, printing or use of the Information, whether such liabilities, costs, expenses, damages and losses arise following subsequent disclosure by you to any third party or otherwise. 

ix. CBMM is not liable for and shall not indemnify you in any way for any liability, costs, expenses, damages or losses suffered or incurred as the result of the use by you or a third party of the Information. In particular, CBMM shall not be liable for any damage to your computer or electronic device, or for any loss of data caused by your downloading or use of this electronic file. 

x. CBMM does not warrant nor legally represent that your use of the Information does not infringe upon the rights of third parties or that the Information is correct or complete. 

xi. This disclaimer is governed by the laws of the Netherlands. The competent court in Amsterdam, the Netherlands, shall have exclusive jurisdiction in any disputes arising under, or in connection with, this disclaimer. 
Clause 2 Copyright 

i. User acknowledges that all Materials are protected under Copyright Law, and that CBMM exclusively authorizes the personal use of the Materials by the user, being forbidden any form of commercial use, such as the reproduction, the redistribution, the edition, the resale or the creation of derivative works. If the user has an interest in any form of commercial use of the Materials, please send an e-mail to CBMM asking for specific information and/or authorization. 

ii. If you believe that any of the Materials infringe user's copyright, please send an e-mail to CBMM with detailed information identifying the Material and the user's copyright that might have been violated. Please note that we may reproduce the e-mail to the Material's author and to the copyright owner in order to obtain further information on the matter, prior to the decision of either removing the Material or maintaining it on the website. 

iii. The user may quote the Material in any scientific work provided that the user is the author of the scientific work or all the credits are duly mentioned, including information regarding the author, the copyright ownership and the website in which the material can be accessed.